EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RBM15 exacerbates airway inflammation in asthma by activating NF-κB through the m6A-YTHDF2 axis

Na Chen, Weizhou Wang, Yang Yang, Zhu Chen

Immunobiology · 2026-11 · 231 (6) · 153251

DOI: 10.1016/j.imbio.2026.153251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunobiology, 2026-11. Verfasst von Na Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Second Clinical Medical College of Guizhou University of Chinese Medicine, Guiyang City, Guizhou Province 550003, China. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guizhou Provincial Science and Technology Department, Health Commission of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

m6A methylation modification participates in the regulation of inflammatory responses, whereas the specific role and related mechanism of its cofactor RBM15 in asthma remain poorly defined. This study aimed to explore the function of RBM15 in allergic asthma and further elucidate its molecular mechanism regulating the NF-κB pathway through the m6A-YTHDF2-TNFAIP3 axis. In this research, an OVA-induced mouse allergic asthma model was established to detect RBM15 expression and assess the influences of RBM15 knockdown on airway inflammation, airway hyperresponsiveness and Th2 immune response. Besides, TNF-α was applied to construct an in vitro inflammatory model of airway epithelial cells. Western blot, mRNA stability detection, m6A-MeRIP-qPCR and RIP-qPCR were adopted to explore the mechanism by which RBM15 modulates TNFAIP3, and YTHDF2 complementation experiment was performed to confirm the function of this regulatory axis. The results revealed that RBM15 was highly expressed in lung tissues of asthmatic mice. Silencing RBM15 could alleviate airway inflammation, decrease serum IgE and Th2 cytokine levels, and ameliorate airway hyperresponsiveness. In vitro assays verified that RBM15 elevated the m6A modification level of TNFAIP3 mRNA, thereby facilitating YTHDF2-dependent degradation of TNFAIP3 mRNA, suppressing TNFAIP3 expression and triggering NF-κB pathway activation. RBM15 knockdown recovered TNFAIP3 expression and blocked NF-κB signaling, and such changes could be rescued by YTHDF2 overexpression. Collectively, inhibition of RBM15 relieves airway inflammation and airway hyperresponsiveness in allergic asthma via the m6A-YTHDF2-TNFAIP3 axis.

Schlagwörter

Stichwörter der Autor:innen

AsthmaNF-κBRBM15TNFAIP3YTHDF2

Autor:innen und Institutionen

  • Department of Pediatrics, The Second Clinical Medical College of Guizhou University of Chinese Medicine, Guiyang City, Guizhou Province 550003, China.
  • Department of Pediatrics, The Second Clinical Medical College of Guizhou University of Chinese Medicine, Guiyang City, Guizhou Province 550003, China. Electronic address: zchen1542@163.com.

Förderung

  • Guizhou Provincial Science and Technology Department
  • Health Commission of Guizhou Province

Zitieren

APA

Chen, N., Wang, W., Yang, Y., & Chen, Z. (2026). RBM15 exacerbates airway inflammation in asthma by activating NF-κB through the m6A-YTHDF2 axis. Immunobiology, 231(6), 153251. https://doi.org/10.1016/j.imbio.2026.153251

Vancouver

Chen N, Wang W, Yang Y, Chen Z. RBM15 exacerbates airway inflammation in asthma by activating NF-κB through the m6A-YTHDF2 axis. Immunobiology. 2026;231(6):153251. doi:10.1016/j.imbio.2026.153251

BibTeX
@article{Chen2026,
  author = {Chen, Na and Wang, Weizhou and Yang, Yang and Chen, Zhu},
  title = {RBM15 exacerbates airway inflammation in asthma by activating NF-κB through the m6A-YTHDF2 axis},
  journal = {Immunobiology},
  year = {2026},
  volume = {231},
  number = {6},
  pages = {153251},
  doi = {10.1016/j.imbio.2026.153251}
}
Kostenlos starten →